Biofidelity Unveils Revolutionary Enspyre® Technology at AGBT 2025 Biofidelity is set to debut its groundbreaking sequencing technology, Enspyre®, aimed at enhancing genomic analysis for cancer diagnostics at AGBT 2025.

Biofidelity Unveils Revolutionary Enspyre® Technology at AGBT 2025 #United_States #Florida #Biofidelity #Enspyre #Genomic_Technology